Cargando…

Key considerations for conducting Chinese medicine clinical trials in hospitals

Conducting clinical trials of Chinese medicines (CM) in hospitals presents challenges for researchers. The success of hospital-based CM clinical trials may be influenced by the protocol design, including the maintenance of CM theory in compliance with scientific rigour and hospital guidelines and ju...

Descripción completa

Detalles Bibliográficos
Autores principales: Shergis, Johannah L, Parker, Shefton, Coyle, Meaghan E, Zhang, Anthony L, Xue, Charlie C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577434/
https://www.ncbi.nlm.nih.gov/pubmed/23414529
http://dx.doi.org/10.1186/1749-8546-8-3
_version_ 1782259909985828864
author Shergis, Johannah L
Parker, Shefton
Coyle, Meaghan E
Zhang, Anthony L
Xue, Charlie C
author_facet Shergis, Johannah L
Parker, Shefton
Coyle, Meaghan E
Zhang, Anthony L
Xue, Charlie C
author_sort Shergis, Johannah L
collection PubMed
description Conducting clinical trials of Chinese medicines (CM) in hospitals presents challenges for researchers. The success of hospital-based CM clinical trials may be influenced by the protocol design, including the maintenance of CM theory in compliance with scientific rigour and hospital guidelines and justified treatment approaches with results that can translate into clinical practice. Other influences include personnel and resources such as a dedicated team open to CM with an established research culture and the ability to maximise participant recruitment. This article identifies the key challenges and limitations of conducting CM clinical trials in Australian hospitals.
format Online
Article
Text
id pubmed-3577434
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35774342013-02-21 Key considerations for conducting Chinese medicine clinical trials in hospitals Shergis, Johannah L Parker, Shefton Coyle, Meaghan E Zhang, Anthony L Xue, Charlie C Chin Med Commentary Conducting clinical trials of Chinese medicines (CM) in hospitals presents challenges for researchers. The success of hospital-based CM clinical trials may be influenced by the protocol design, including the maintenance of CM theory in compliance with scientific rigour and hospital guidelines and justified treatment approaches with results that can translate into clinical practice. Other influences include personnel and resources such as a dedicated team open to CM with an established research culture and the ability to maximise participant recruitment. This article identifies the key challenges and limitations of conducting CM clinical trials in Australian hospitals. BioMed Central 2013-02-16 /pmc/articles/PMC3577434/ /pubmed/23414529 http://dx.doi.org/10.1186/1749-8546-8-3 Text en Copyright ©2013 Shergis et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Shergis, Johannah L
Parker, Shefton
Coyle, Meaghan E
Zhang, Anthony L
Xue, Charlie C
Key considerations for conducting Chinese medicine clinical trials in hospitals
title Key considerations for conducting Chinese medicine clinical trials in hospitals
title_full Key considerations for conducting Chinese medicine clinical trials in hospitals
title_fullStr Key considerations for conducting Chinese medicine clinical trials in hospitals
title_full_unstemmed Key considerations for conducting Chinese medicine clinical trials in hospitals
title_short Key considerations for conducting Chinese medicine clinical trials in hospitals
title_sort key considerations for conducting chinese medicine clinical trials in hospitals
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577434/
https://www.ncbi.nlm.nih.gov/pubmed/23414529
http://dx.doi.org/10.1186/1749-8546-8-3
work_keys_str_mv AT shergisjohannahl keyconsiderationsforconductingchinesemedicineclinicaltrialsinhospitals
AT parkershefton keyconsiderationsforconductingchinesemedicineclinicaltrialsinhospitals
AT coylemeaghane keyconsiderationsforconductingchinesemedicineclinicaltrialsinhospitals
AT zhanganthonyl keyconsiderationsforconductingchinesemedicineclinicaltrialsinhospitals
AT xuecharliec keyconsiderationsforconductingchinesemedicineclinicaltrialsinhospitals